Science Explorer Back to mapMap
Discussion
Company · Bad Homburg · Germany

Eli Lilly (Germany)

In research, Eli Lilly (Germany) stands highest in Health Sciences (#6,998 of 16,688 worldwide) and Medicine (#6,561 of 14,558 worldwide), over all time.

lilly.comROR OpenAlex
World rank, all time
#23,865
of 34,923
Rank in Germany
#1,163
of 1,603
Research works
318
▼ 47% vs 2018-21
Citations
9.7k
30.5 per fractional work
Top-10% rate
10.6%
all institutions 10.0%
vs its own fields
0.97×
1.00× is exactly expected
Open access
26%
world 40%
International
52%
world 18%
Eli Lilly (Germany)

What is Eli Lilly (Germany) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #6,998 of 16,688 8.1%219
MedicineField #6,561 of 14,558 7.5%210

Each strip is that field's whole ranked pool, with the notch where Eli Lilly (Germany) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Eli Lilly (Germany) work in?

In all years, 69% of research at Eli Lilly (Germany) is in Health Sciences, 19% in Life Sciences. Its largest fields are Medicine (66%), Biochemistry, Genetics and Molecular Biology (12%), Neuroscience (5%). It does 2.9× the world's share of Health Sciences.

Health Sciences: 219 fractional works · 68.9% of its workMedicine: 210 fractional works · 65.9% of its workEndocrinology, Diabetes and Metabolism: 60 fractional works · 18.8% of its workPsychiatry and Mental health: 25 fractional works · 7.8% of its workSurgery: 15 fractional works · 4.6% of its workOncology: 15 fractional works · 4.6% of its workPulmonary and Respiratory Medicine: 13 fractional works · 4.2% of its workPharmacology: 12 fractional works · 3.8% of its workEpidemiology: 10 fractional works · 3.1% of its workPhysiology: 8 fractional works · 2.6% of its workCardiology and Cardiovascular Medicine: 8 fractional works · 2.6% of its workPediatrics, Perinatology and Child Health: 6 fractional works · 1.9% of its workRheumatology: 5 fractional works · 1.7% of its workPublic Health, Environmental and Occupational Health: 5 fractional works · 1.4% of its workNeurology: 4 fractional works · 1.3% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 0.6% of its workGenetics: 2 fractional works · 0.6% of its workPathology and Forensic Medicine: 2 fractional works · 0.5% of its workNephrology: 2 fractional works · 0.5% of its workObstetrics and Gynecology: 2 fractional works · 0.5% of its workUrology: 1 fractional works · 0.5% of its workReproductive Medicine: 1 fractional works · 0.4% of its workCritical Care and Intensive Care Medicine: 1 fractional works · 0.4% of its workOrthopedics and Sports Medicine: 1 fractional works · 0.4% of its workInfectious Diseases: 1 fractional works · 0.3% of its workComplementary and alternative medicine: 1 fractional works · 0.3% of its workHematology: 1 fractional works · 0.3% of its workFamily Practice: 1 fractional works · 0.3% of its workOphthalmology: 1 fractional works · 0.3% of its workHepatology: 1 fractional works · 0.3% of its workDermatology: 1 fractional works · 0.3% of its workGastroenterology: 1 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 0.7% of its workHealth Professions: 7 fractional works · 2.3% of its workGeneral Health Professions: 6 fractional works · 1.7% of its workPharmacy: 1 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.3% of its workNursing: 2 fractional works · 0.7% of its workNutrition and Dietetics: 2 fractional works · 0.7% of its workDentistry: 0 fractional works · 0.0% of its workLife Sciences: 59 fractional works · 18.7% of its workBiochemistry, Genetics and Molecular Biology: 37 fractional works · 11.7% of its workMolecular Biology: 25 fractional works · 7.7% of its workGenetics: 7 fractional works · 2.1% of its workCancer Research: 3 fractional works · 1.0% of its workBiotechnology: 1 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 0.6% of its workNeuroscience: 16 fractional works · 4.9% of its workEndocrine and Autonomic Systems: 7 fractional works · 2.1% of its workCognitive Neuroscience: 5 fractional works · 1.5% of its workCellular and Molecular Neuroscience: 2 fractional works · 0.8% of its workNeurology: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.3% of its workImmunology and Microbiology: 3 fractional works · 1.1% of its workImmunology: 3 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 0.6% of its workPharmacology: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.3% of its workAgricultural and Biological Sciences: 1 fractional works · 0.3% of its workSocial Sciences: 28 fractional works · 8.7% of its workPsychology: 14 fractional works · 4.5% of its workClinical Psychology: 9 fractional works · 2.9% of its workExperimental and Cognitive Psychology: 4 fractional works · 1.3% of its workSocial Psychology: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 8 fractional works · 2.4% of its workEconomics and Econometrics: 8 fractional works · 2.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 2 fractional works · 0.6% of its workStrategy and Management: 1 fractional works · 0.4% of its workSmaller subfields together: 1 fractional works · 0.2% of its workArts and Humanities: 2 fractional works · 0.5% of its workPhilosophy: 2 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workDecision Sciences: 1 fractional works · 0.3% of its workStatistics, Probability and Uncertainty: 1 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 0.2% of its workPhysical Sciences: 12 fractional works · 3.7% of its workChemistry: 7 fractional works · 2.2% of its workOrganic Chemistry: 6 fractional works · 1.9% of its workInorganic Chemistry: 1 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMathematics: 2 fractional works · 0.7% of its workStatistics and Probability: 2 fractional works · 0.7% of its workComputer Science: 2 fractional works · 0.5% of its workComputational Theory and Mathematics: 1 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 1 fractional works · 0.2% of its workEngineering: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.0% of its workALL ITS WORKEli Lilly(Germany)318fractional works, all years
Life Sciences19%Physical Sciences4%Health Sciences69%Social Sciences9%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 23 fields, with their numbers
    1. Medicine21065.9%
    2. Health Professions72.3%
    3. Nursing20.7%
    4. Dentistry00.0%
    5. Veterinary00.0%
    1. Biochemistry, Genetics and Molecular Biology3711.7%
    2. Neuroscience164.9%
    3. Immunology and Microbiology31.1%
    4. Pharmacology, Toxicology and Pharmaceutics20.6%
    5. Agricultural and Biological Sciences10.3%
    1. Psychology144.5%
    2. Economics, Econometrics and Finance82.4%
    3. Business, Management and Accounting20.6%
    4. Arts and Humanities20.5%
    5. Decision Sciences10.3%
    6. Social Sciences10.2%
    1. Chemistry72.2%
    2. Mathematics20.7%
    3. Computer Science20.5%
    4. Materials Science10.2%
    5. Engineering00.1%
    6. Environmental Science00.1%
    7. Physics and Astronomy00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.13× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 2.51× its world share, 0 worksImmunology and Micro…Neuroscience: 0.51× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.79× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.10× its world share, 0 worksComputer ScienceMaterials Science: 0.20× its world share, 0 worksMaterials ScienceDentistry: 0.09× its world share, 0 worksDentistryHealth Professions: 1.19× its world share, 1 worksHealth ProfessionsMedicine: 4.01× its world share, 14 worksMedicineBusiness, Management and Accounting: 0.07× its world share, 0 worksBusiness, Management…Decision Sciences: 0.39× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.61× its world share, 0 worksEconomics, Econometr…Psychology: 0.12× its world share, 0 worksPsychologySocial Sciences: 0.05× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.

All 14 fields, with their numbers
  1. Medicine4.01×14 works
  2. Immunology and Microbiology2.51×0 works
  3. Biochemistry, Genetics and Molecular Biology2.13×2 works
  4. Pharmacology, Toxicology and Pharmaceutics1.79×0 works
  5. Health Professions1.19×1 works
  6. Economics, Econometrics and Finance0.61×0 works
  7. Neuroscience0.51×0 works
  8. Decision Sciences0.39×0 works
  9. Materials Science0.20×0 works
  10. Psychology0.12×0 works
  11. Computer Science0.10×0 works
  12. Dentistry0.09×0 works
  13. Business, Management and Accounting0.07×0 works
  14. Social Sciences0.05×0 works

Who are the top researchers at Eli Lilly (Germany)?

Ranked on the quality score, Claudia Nicolay, Beatrix Bálint and Piera Englaro lead among researchers whose main affiliation is Eli Lilly (Germany).

  1. 1 Claudia Nicolay Germany · #725,969 worldwide 2.9k citations · 106 works
  2. 2 Beatrix Bálint Germany · #932,876 worldwide 2.1k citations · 38 works
  3. 3 Piera Englaro Germany · #944,502 worldwide 3.7k citations · 41 works
  4. 4 J. Blatter Germany · #1,551,020 worldwide 3.5k citations · 88 works
  5. 5 W. F. P. Blum Germany · #1,657,949 worldwide 1.9k citations · 43 works
  6. 6 W. F. Blum Germany · #1,874,178 worldwide 1.6k citations · 30 works
  7. 7 Alexander Schacht Germany · #2,150,763 worldwide 4.1k citations · 120 works
  8. 8 Peter M. Wehmeier Germany · #2,196,353 worldwide 2.2k citations · 46 works
  9. 9 Carsten Henneges Germany · #2,337,260 worldwide 1.9k citations · 93 works
  10. 10 Ute Ohnmacht Germany · #2,619,995 worldwide 712 citations · 24 works
All ranked researchers at Eli Lilly (Germany)

What are the most cited papers from Eli Lilly (Germany)?

The most cited paper from Eli Lilly (Germany) is "Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial" (Hansjochen Wilke, Kei Muro, Eric Van Cutsem et al., 2014), with 2,505 citations. Next come "FGF-21 as a novel metabolic regulator" (2,126) and "The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies" (694).

Most cited papers
#PaperReleasedCitations
1 Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial Hansjochen Wilke, Kei Muro, Eric Van Cutsem et al. · The Lancet Oncology 17 Sep 2014 2,505
2 FGF-21 as a novel metabolic regulator Alexei Kharitonenkov, Tatiyana L. Shiyanova, Anja Köester et al. · Journal of Clinical Investigation Open access 3 May 2005 2,126
3 The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies Giorgio V. Scagliotti, Nasser H. Hanna, Frank V. Fossella et al. · The Oncologist Open access 16 Feb 2009 694
4 Social and Emotional Impairment in Children and Adolescents with ADHD and the Impact on Quality of Life Peter M. Wehmeier, Alexander Schacht, Russell A. Barkley · Journal of Adolescent Health 5 Jan 2010 631
5 Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway Michael M. F. Lahn, Stephan Herbertz, J. Scott Sawyer et al. · Drug Design Development and Therapy Open access Aug 2015 552
All 60 most cited papers, with filters and sorting

Which keywords describe research at Eli Lilly (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Cardiovascular Disease, Diabetes, Clinical Guidelines, Type 2 Diabetes, Heart Failure and Obesity.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycemic Control45▲ 103×4 topics
  2. Insulin Therapy42▲ 120×3 topics
  3. Cardiovascular Disease31▲ 8.8×21 topics
  4. Diabetes28▲ 17×13 topics
  5. Clinical Guidelines27▲ 28×6 topics
  6. Type 2 Diabetes26▲ 44×5 topics
  7. Heart Failure23▲ 16×8 topics
  8. Epidemiology22▲ 1.72×49 topics
  9. Cardiovascular Outcomes21▲ 159×1 topic
  10. Glucose Control21▲ 159×1 topic
  11. Obesity21▲ 8.8×14 topics
  12. Metabolic Syndrome20▲ 7.5×20 topics
  13. Type 1 Diabetes20▲ 69×2 topics
  14. Clinical Trials20▲ 9.9×13 topics
  15. Complications18▲ 11×5 topics
  16. Continuous Glucose Monitoring18▲ 123×1 topic
  17. Hypoglycemia18▲ 123×1 topic
  18. Inflammation16▲ 2.1×39 topics
  19. Quality of Life15▲ 3.6×16 topics
  20. Depression14▲ 6.0×13 topics
  21. Genetics13▲ 5.4×10 topics
  22. Chemotherapy13▲ 5.7×19 topics
  23. Prevalence10▲ 7.7×6 topics
  24. Tumor Suppression10▲ 27×3 topics
  25. Immunotherapy10▲ 4.6×14 topics
  26. Neurobiology10▲ 9.0×6 topics
  27. Diabetes Mellitus9▲ 13×6 topics
  28. Targeted Therapy9▲ 14×5 topics
  29. Cancer Risk9▲ 11×2 topics
  30. Treatment Guidelines9▲ 14×3 topics
  31. AMP-Activated Protein Kinase9▲ 58×2 topics
  32. Glucose9▲ 71×1 topic
  33. Metformin9▲ 71×1 topic
  34. Insulin Resistance8▲ 5.7×7 topics
  35. Weight Loss8▲ 16×4 topics
  36. Antipsychotic Drugs8▲ 48×1 topic
  37. Neurocognitive Deficits8▲ 48×1 topic
  38. Comorbidity7▲ 23×2 topics
  39. Hormonal Regulation7▲ 39×2 topics
  40. Growth Hormone7▲ 25×2 topics

Which research topics does Eli Lilly (Germany) publish most on?

By volume in 2022-now: Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer and Bariatric Surgery and Outcomes.

Diabetes Treatment and M…2Diabetes Treatment and Management: 2 fractional worksDiabetes Management and …1Diabetes Management and Research: 1 fractional worksMetabolism, Diabetes, an…1Metabolism, Diabetes, and Cancer: 1 fractional worksBariatric Surgery and Outcomes: 0 fractional worksDiabetes and associated disorders: 0 fractional worksBreast Cancer Treatment …0Breast Cancer Treatment Studies: 0 fractional worksPharmacology and Obesity Treatment: 0 fractional worksMigraine and Headache Studies: 0 fractional worksAdvanced Breast Cancer Therapies: 0 fractional worksDiet and metabolism studies: 0 fractional works
Endocrinology, Diabetes and MetabolismMolecular BiologySurgeryGenetics5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 2 works
  2. 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 1 works
  3. 3 Metabolism, Diabetes, and Cancer Molecular Biology 1 works
  4. 4 Bariatric Surgery and Outcomes Surgery 0 works
  5. 5 Diabetes and associated disorders Genetics 0 works
  6. 6 Breast Cancer Treatment Studies Cancer Research 0 works
  7. 7 Pharmacology and Obesity Treatment Pharmacology 0 works
  8. 8 Migraine and Headache Studies Psychiatry and Mental health 0 works
  9. 9 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  10. 10 Diet and metabolism studies Physiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available26.4%not open73.6%

World: 40% of research is openly available.

with international co-authors51.5%domestic only48.5%

World: 18% is written across borders.

How has Eli Lilly (Germany)'s research output changed?

Output in 2022-2025 was 47% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Eli Lilly (Germany) as a percentage of every work published that year, 0.000058% in 2024.

still counting0.00050%0.0010%0.0015%Eli Lilly (Germany)0.000043% in 202519801990200020102020

Fractional works of Eli Lilly (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Bad Homburg

All research institutions in Bad Homburg

Share Eli Lilly (Germany)'s ranking

Eli Lilly (Germany) on Science Explorer

A card with Eli Lilly (Germany)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Eli Lilly (Germany). Posts are plain text and can be reported.